Contact
Please use this form to send email to PR contact of this press release:
Personalized Stem Cells Announces Licensing Agreement for its Allogeneic Stem Cell Program Including COVID-19 Therapy
TO:
Michael Dale, President/COO
Personalized Stem Cells, Inc
+ +1 833-772-3557